Gastrointestinal Cancers: Progress with Targeted Therapies
/
RSS Feed
Robert Mayer
ROBERT MAYER, Dana-Farber Cancer Institute, Boston
One of the leading participants at the 2008 Gastrointestinal Cancers Symposium, Robert Mayer, gave Peter Goodwin his assessment of some of the emerging new therapies being announced, for colorectal, liver and pancreas cancers.
One of the leading participants at the 2008 Gastrointestinal Cancers Symposium, Robert Mayer, gave Peter Goodwin his assessment of some of the emerging new therapies being announced, for colorectal, liver and pancreas cancers.
LISTEN
[audio:https://www.audiomedica.com/podcasting/oncology/080126_robert_mayer.mp3]
You may also like...
Audio Journal of Oncology in Advance – April 15th, 2007 – Bisphosphonates Recommended for Lung Cancer Bone Metastases 15 Apr, 2007 
Geriatric Assessment Improved Outcomes for Older Patients with Cancer 11 Jul, 2018 - ASCO Audio Journal of Oncology in Advance – June 15th, 2007 – reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007 16 Jun, 2007
- ALK—Targeted Lung Cancer Drugs Benefited Real World Patients 7 Nov, 2018
